EXRASE Trademark

Trademark Overview


On Thursday, April 24, 2025, a trademark application was filed for EXRASE with the United States Patent and Trademark Office. The USPTO has given the EXRASE trademark a serial number of 79426080. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, September 16, 2025. This trademark is owned by enGenes Biotech GmbH. The EXRASE trademark is filed in the Chemical Products category with the following description:

Chemicals for use in industry and science, in particular DNA endonucleases
exrase

General Information


Serial Number79426080
Word MarkEXRASE
Filing DateThursday, April 24, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, September 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemicals for use in industry and science, in particular DNA endonucleases

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 19, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameenGenes Biotech GmbH
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressAT

Trademark Events


Event DateEvent Description
Thursday, June 19, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, June 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 24, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, September 16, 2025ASSIGNED TO EXAMINER
Tuesday, September 16, 2025NON-FINAL ACTION WRITTEN
Wednesday, September 17, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW